We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BellRing Brands (BRBR) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
BellRing Brands (BRBR - Free Report) closed the latest trading day at $77.06, indicating a +0.51% change from the previous session's end. The stock exceeded the S&P 500, which registered a loss of 0.3% for the day. Meanwhile, the Dow experienced a drop of 0.35%, and the technology-dominated Nasdaq saw a decrease of 0.25%.
Coming into today, shares of the nutritional supplements company had gained 7.5% in the past month. In that same time, the Medical sector lost 3.43%, while the S&P 500 gained 1.09%.
The investment community will be closely monitoring the performance of BellRing Brands in its forthcoming earnings report. The company is predicted to post an EPS of $0.47, indicating a 9.3% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $522.09 million, indicating a 21.3% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $2.16 per share and a revenue of $2.29 billion, signifying shifts of +11.92% and +14.78%, respectively, from the last year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for BellRing Brands. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 3.52% higher. BellRing Brands is currently a Zacks Rank #2 (Buy).
From a valuation perspective, BellRing Brands is currently exchanging hands at a Forward P/E ratio of 35.47. This expresses a premium compared to the average Forward P/E of 26.09 of its industry.
We can also see that BRBR currently has a PEG ratio of 2.57. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Products industry currently had an average PEG ratio of 2.39 as of yesterday's close.
The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 129, putting it in the bottom 49% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
BellRing Brands (BRBR) Gains As Market Dips: What You Should Know
BellRing Brands (BRBR - Free Report) closed the latest trading day at $77.06, indicating a +0.51% change from the previous session's end. The stock exceeded the S&P 500, which registered a loss of 0.3% for the day. Meanwhile, the Dow experienced a drop of 0.35%, and the technology-dominated Nasdaq saw a decrease of 0.25%.
Coming into today, shares of the nutritional supplements company had gained 7.5% in the past month. In that same time, the Medical sector lost 3.43%, while the S&P 500 gained 1.09%.
The investment community will be closely monitoring the performance of BellRing Brands in its forthcoming earnings report. The company is predicted to post an EPS of $0.47, indicating a 9.3% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $522.09 million, indicating a 21.3% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $2.16 per share and a revenue of $2.29 billion, signifying shifts of +11.92% and +14.78%, respectively, from the last year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for BellRing Brands. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 3.52% higher. BellRing Brands is currently a Zacks Rank #2 (Buy).
From a valuation perspective, BellRing Brands is currently exchanging hands at a Forward P/E ratio of 35.47. This expresses a premium compared to the average Forward P/E of 26.09 of its industry.
We can also see that BRBR currently has a PEG ratio of 2.57. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Products industry currently had an average PEG ratio of 2.39 as of yesterday's close.
The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 129, putting it in the bottom 49% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.